CLINICAL ROLE -
Study Data Suggests Sustained Safety, Efficacy of Lanadelumab in Adolescents With HAE
The data comes from 2 phase 4 trials, ENABLE and EMPOWER, which evaluated lanadelumab and the outcomes of treatment in adolescents with hereditary angioedema.